Recently, a new NCWP involving Wnt5a and the receptor Frizzled2 (Fzd2) was discovered (Figure 1D) and shown to promote tumor progression and EMT in several cancer cell lines and a mouse xenograft model [22]. This evidence concerns the gene FZD2 and cancer.